GKV Capital Management Co. Inc. Buys 2,650 Shares of UnitedHealth Group Incorporated $UNH

by · The Cerbat Gem

GKV Capital Management Co. Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 181.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,110 shares of the healthcare conglomerate’s stock after buying an additional 2,650 shares during the quarter. GKV Capital Management Co. Inc.’s holdings in UnitedHealth Group were worth $2,153,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of UNH. GAMMA Investing LLC boosted its holdings in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. Nuveen LLC purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $3,846,764,000. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its holdings in shares of UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on UNH shares. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. TD Securities reissued a “hold” rating and issued a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $353.00.

Check Out Our Latest Analysis on UNH

UnitedHealth Group Price Performance

UNH stock opened at $302.66 on Friday. The firm has a 50 day moving average price of $288.01 and a 200-day moving average price of $383.24. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market capitalization of $274.11 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.96 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).